Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Mustela putorius furo Homo sapiens

PROVIDER: GSE180391 | GEO | 2022/04/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets [RT-PCR]

Project description:Probiotics have been suggested as one solution to counter detrimental health effects by SARS-CoV-2, however, data so far is scarce. We tested the effect of two probiotic consortia, OL-1 and OL-2, against SARS-CoV2 in ferrets and assessed their effect on cytokine production and transcriptome in a human monocyte- derived macrophage (Mf) and dendritic cell (DC) model. The results showed that the consortia significantly reduced the viral load, modulated immune response, and regulated viral receptor expression in ferrets compared to placebo. In human Mf and DC model, OL-1 and OL-2 induced cytokine production and genes and related to SARS-CoV-2 anti-viral immunity. The study results indicate that probiotic stimulation of the ferret immune system leads to improved anti-viral immunity against SARS-COV-2 and that critical genes and cytokines for anti-SARS-CoV-2 immunity are stimulated in human immune cells in vitro. The effect of the consortia against SARS-CoV-2 warrants further investigations in human clinical trials.

2022-04-01 | GSE180390 | GEO

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets [RNA-seq]

2022-04-01 | GSE180389 | GEO

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets

Project description:Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets

| PRJNA748042 | ENA

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets [RT-PCR]

Project description:Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets [RT-PCR]

| PRJNA748048 | ENA

Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets [RNA-seq]

Project description:Probiotic consortia improve anti-viral immunity to SARS-CoV-2 in Ferrets [RNA-seq]

| PRJNA748049 | ENA

Viral anti-inflammatory serpin reduces immuno-coagulopathic pathology in SARS-CoV-2 infection

Project description: Not available

| S-SCDT-10_15252-EMMM_202317376 | biostudies-other

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2

Project description:The immune responses and mechanisms limiting symptom progression in asymptomatic cases of SARS-CoV-2 infection remain unclear. We comprehensively characterized transcriptomic profiles, cytokine responses, neutralization capacity of antibodies and cellular immune phenotypes of asymptomatic patients with acute SARS-CoV-2 infection to identify potential protective mechanisms. Compared to symptomatic patients, asymptomatic patients had higher counts of mature neutrophils and lower proportion of CD169+ expressing monocytes in the peripheral blood. Systemic levels of pro-inflammatory cytokines were also lower in asymptomatic patients, accompanied by milder pro-inflammatory gene signatures. Mechanistically, a more robust systemic Th2 cell signature with a higher level of virus-specific Th17 cells and a weaker yet sufficient neutralizing antibody profile against SARS-CoV-2 was observed in asymptomatic patients. In addition, asymptomatic COVID-19 patients had higher systemic levels of growth factors that are associated with cellular repair. Together, asymptomatic patients mount less pro-inflammatory and more protective immune responses against SARS-CoV-2 indicative of disease tolerance. Insights from this study highlight key immune pathways that could serve as therapeutic targets to prevent disease progression in COVID-19.

2021-04-24 | GSE166424 | GEO

Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.

Project description: Not available

| S-EPMC8185544 | biostudies-literature

Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies

Project description: Not available

| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other

Sex and age bias viral burden and interferon responses during SARS-CoV-2 infection in ferrets.

Project description: Not available

| S-EPMC8282673 | biostudies-literature